Remove keyword emerging-markets
article thumbnail

Pharma brands must ‘up the ante’ in their digital presence

pharmaphorum

Pharma businesses need to ensure that they market themselves accordingly to both B2B and B2C. The good news is Pharma businesses have the opportunity to use a multitude of digital marketing channels to advertise on such as LinkedIn, YouTube, Google and Twitter. How to maximise your digital marketing strategy.

Branding 109
article thumbnail

Grand Rounds February 23, 2024: Virtual Vigilance: Monitoring of Decentralized Clinical Trials (Adrian Hernandez, MD; Christopher J. Lindsell, PhD)

Rethinking Clinical Trials

The global decentralized clinical trial market is expected to grow at a compound annual growth rate of 30.1% from 2021 to 2026. I think we must. One of the things we are in the process of sharing in terms of what we are observing is putting new procedures for what we monitor in a study.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

Prominent Reasons Behind The Failure Of NAMPT inhibitors And Key Strategies Adopted By Developers To Overcome Such Challenges

Roots Analysis

Challenges Faced by NAMPT Inhibitors NAMPT inhibitors have emerged as a promising target for the development of therapies against a range of disease indications, especially, the different forms of cancers. Additionally, NAMPT inhibitors can have off-target effects, which can lead to toxicity and adverse side effects.

article thumbnail

What HCPs think about medical tweetorials

pharmaphorum

As Tony Breu , a hospitalist in Boston puts it , tweetorials are a form of threaded tweets that have emerged as a tool for medical education and knowledge dissemination. When users reply to a thread mentioning the bot and using the keyword “unroll” the bot comments returning a link to the full thread in one article.

Doctors 125